As populations age worldwide, the burden of valvular heart disease has grown
exponentially, and so has the proportion of affected women. Although rheumatic valve …

Cardiovascular disease remains the leading cause of morbidity and mortality for women in
United States and worldwide. One in 3 women dies from cardiovascular disease, and 45 …

Importance Left atrial appendage occlusion (LAAO) has emerged as an alternative to
anticoagulation for select patients with atrial fibrillation; however, women have been …

Transcatheter aortic valve replacement (TAVR) has gained over time a major reduction in
procedural complications. Despite this, clinically relevant bleeding still occurs in a non …

Objectives This study evaluated the feasibility and safety of same-day discharge (SDD)
following transfemoral transcatheter aortic valve replacement (TF-TAVR) compared with next …

Antithrombotic therapy after cardiac percutaneous interventions is key for the prevention of
thrombotic events but is inevitably associated with increased bleeding, proportional to the …

Numerous sex-based differences are observed across the spectrum of valvular heart
disease, starting with pathophysiology and progression of disease, moving on to …

The development of new devices and treatment options has greatly increased the interest in
heart valve diseases. In this context, the consideration of gender differences in diagnosis …

Objectives The authors aimed to identify risk factors and outcomes associated with new-
onset atrial fibrillation (NOAF) after transcatheter aortic valve replacement (TAVR) …

Objectives This study sought to evaluate the trends and outcomes of transcatheter aortic
valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) among patients …